These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 28396716)
21. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. Thanee M; Loilome W; Techasen A; Namwat N; Boonmars T; Pairojkul C; Yongvanit P Asian Pac J Cancer Prev; 2015; 16(7):3043-50. PubMed ID: 25854403 [TBL] [Abstract][Full Text] [Related]
22. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma. Liu B; Hu Y; Qin L; Peng XB; Huang YX Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946 [TBL] [Abstract][Full Text] [Related]
24. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
25. Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine. Carloni R; Rizzo A; Ricci AD; Federico AD; De Luca R; Guven DC; Yalcin S; Brandi G Transl Oncol; 2022 Nov; 25():101514. PubMed ID: 35977458 [TBL] [Abstract][Full Text] [Related]
26. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Kang N; Shah VH; Urrutia R Mol Cancer Res; 2015 Apr; 13(4):604-12. PubMed ID: 25548101 [TBL] [Abstract][Full Text] [Related]
27. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? Romano M; De Francesco F; Gringeri E; Giordano A; Ferraro GA; Di Domenico M; Cillo U J Cell Physiol; 2016 Apr; 231(4):768-76. PubMed ID: 26357947 [TBL] [Abstract][Full Text] [Related]
28. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts. Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490 [TBL] [Abstract][Full Text] [Related]
29. Stroma as an Active Player in the Development of the Tumor Microenvironment. Vannucci L Cancer Microenviron; 2015 Dec; 8(3):159-66. PubMed ID: 25106539 [TBL] [Abstract][Full Text] [Related]
30. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis. Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031 [TBL] [Abstract][Full Text] [Related]
31. The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets. Farran B; Nagaraju GP Cytokine Growth Factor Rev; 2019 Aug; 48():11-23. PubMed ID: 31331827 [TBL] [Abstract][Full Text] [Related]
32. Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma. Høgdall D; Lewinska M; Andersen JB Trends Cancer; 2018 Mar; 4(3):239-255. PubMed ID: 29506673 [TBL] [Abstract][Full Text] [Related]
33. The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity. Poltavets V; Kochetkova M; Pitson SM; Samuel MS Front Oncol; 2018; 8():431. PubMed ID: 30356678 [TBL] [Abstract][Full Text] [Related]
34. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts. Raggi C; Invernizzi P; Andersen JB J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250 [TBL] [Abstract][Full Text] [Related]
35. The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment. Zhang N; Shu L; Liu Z; Shi A; Zhao L; Huang S; Sheng G; Yan Z; Song Y; Huang F; Tang Y; Zhang Z Front Pharmacol; 2023; 14():1336685. PubMed ID: 38269274 [TBL] [Abstract][Full Text] [Related]
36. The extracellular matrix in tumor progression and metastasis. Eble JA; Niland S Clin Exp Metastasis; 2019 Jun; 36(3):171-198. PubMed ID: 30972526 [TBL] [Abstract][Full Text] [Related]
37. The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. Erkan M; Reiser-Erkan C; Michalski CW; Kong B; Esposito I; Friess H; Kleeff J Curr Mol Med; 2012 Mar; 12(3):288-303. PubMed ID: 22272725 [TBL] [Abstract][Full Text] [Related]
38. Role of Chemokines in the Biology of Cholangiocarcinoma. Caligiuri A; Pastore M; Lori G; Raggi C; Di Maira G; Marra F; Gentilini A Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784743 [TBL] [Abstract][Full Text] [Related]
39. Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer. Wang Y; Xu M; Ke ZJ; Luo J Pharmacol Res; 2017 Jan; 115():299-308. PubMed ID: 27939360 [TBL] [Abstract][Full Text] [Related]